International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients

NCT01111201 | Completed

• 1 other identifier: 10-045
• Study Type: observational
• Target: 26
• Locations: 1 country
• Sites: 1

Brief Summary

This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel. Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.

Conditions

Breast Cancer; Lymphoma

Keywords

Autologous Bone Marrow Transplant; Breast; Lymphoma; International travel; questionnaire; Hematopoietic Stem Cell Transplant (HSCT) recipients

Outcome Measures

Primary Outcomes (1)

• To determine the frequency of international travel of the targeted patients in the last 5 years.

  once at the time of the clinic visit

Secondary Outcomes (4)

• To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised.

  once at the time of the clinic visit

• To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics.

  once at the time of the clinic visit

• To obtain detailed information about their last international trip including

  once at the time of the clinic visit

• To assess the adequacy of the questionnaire instructions

  once at the time of the clinic visit

Study Arms (1)

questionnaires

There will be four versions of the questionnaire, each slightly modified to be more specific toward the treatment paradigms in the respective target patient population (Breast Cancer/ Lymphoma/Autologous Bone Marrow Transplant/ Allogeneic Bone Marrow Transplant). All questionnaire versions will consist of seven sections.

Behavioral: questionnaires

Interventions

questionnaires BEHAVIORAL

The intervention is a self-administered anonymous questionnaire that is voluntarily completed by the patient. Questions in Section One will cover general information about the patient including gender, age, race, country of birth, current zip code of residence, and level of education. Questions in Section Two will cover information regarding the cancer (breast/lymphoma) or transplant (allogeneic/ autologous). Questions in Section Three will cover travel history including the frequency of travel outside the United States and Canada in the last 5 years. Questions in Sections Four through Seven will obtain information about their last trip outside the United States and Canada.

questionnaires

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The goal accrual is 50 patients from each of the following oncology services: Breast, Lymphoma, Autologous Stem Cell Transplant, and Allogeneic Stem Cell Transplant.

You may qualify if:

• Hematopoietic Stem Cell Transplant (HSCT) recipients
• Age \>18 years
• Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3
• Female age \>18 years and current or past history of breast cancer
• Received systemic chemotherapy in the last five years
• Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3
• Age \>18 years and current or past history of lymphoma
• Received systemic chemotherapy within 5 years
• Had active disease at any time within the last 5 years

You may not qualify if:

• Patients age\< 18 years
• Breast cancer and lymphoma patients in clinical remission in the past 5 years
• Patients unable to fill the questionnaire due to language barriers

Sponsors & Collaborators

• Memorial Sloan Kettering Cancer Center: lead

Study Sites (1)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

• Memorial Sloan-Kettering Cancer Center

MeSH Terms

Conditions

Breast Neoplasms; Lymphoma

Interventions

Surveys and Questionnaires

Condition Hierarchy (Ancestors)

Neoplasms by Site; Neoplasms; Breast Diseases; Skin Diseases; Skin and Connective Tissue Diseases; Neoplasms by Histologic Type; Lymphoproliferative Disorders; Lymphatic Diseases; Hemic and Lymphatic Diseases; Immunoproliferative Disorders; Immune System Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Officials

• Monika Shah, MD

  Memorial Sloan Kettering Cancer Center

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 22, 2010
• First Posted: April 27, 2010
• Study Start: April 1, 2010
• Primary Completion: March 1, 2012
• Study Completion: March 1, 2012
• Last Updated: June 1, 2012

Record last verified: 2012-05

Locations

US (1)